Aura Biosciences Inc (AURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | |
| Cash Flows From Operating Activities | |
| Net Income | -17,299 |
| Depreciation Amortization | 605 |
| Accounts payable and accrued liabilities | -1,837 |
| Other Working Capital | -4,427 |
| Other Operating Activity | 2,394 |
| Operating Cash Flow | $-20,564 |
| Cash Flows From Investing Activities | |
| PPE Investments | -639 |
| Investing Cash Flow | $-639 |
| Cash Flows From Financing Activities | |
| Common Stock Issued | 148 |
| Other Financing Activity | 4,755 |
| Financing Cash Flow | $4,903 |
| Beginning Cash Position | 32,543 |
| End Cash Position | 16,243 |
| Net Cash Flow | $-16,300 |
| Free Cash Flow | |
| Operating Cash Flow | -20,564 |
| Capital Expenditure | -639 |
| Free Cash Flow | -21,203 |